Covenant Research

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Fatty liver disease (MASLD/MASH)

Running trials

• Active, not recruiting

  A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

  NCT04951219· Phase 3· Madrigal Pharmaceuticals, Inc.· Source